Skip to main content

Table 3 Logistic regression analysis of features of breast cancers among BRCA1- and BRCA2-associated cases in comparison with non-BRCA1/2 cases

From: Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

 

Odds ratio (95% confidence interval, P)

Feature

BRCA1

BRCA2

First step:

  

Age (continuous)

0.94 (0.91–0.98, 0.0009)

0.94 (0.91–0.97, 0.0001)

Grade (continuous)

3.78 (1.70–8.39, 0.0011)

1.27 (0.71–2.26, 0.42)

ER+

1.0 (referent)

1.0 (referent)

ER-

0.91 (0.28–2.90, 0.88)

0.85 (0.32–2.29, 0.75)

PgR+

1.0 (referent)

1.0 (referent)

PgR-

4.18 (1.26–13.87, 0.019)

1.82 (0.75–4.38, 0.18)

p53+

1.0 (referent)

1.0 (referent)

p53-

1.96 (0.74–5.18, 0.18)

1.61 (0.63–4.12, 0.34)

Final step after stepwise regression:

  

Age (continuous)

0.94 (0.92–0.98, 0.0012)

0.94 (0.92–0.97, 0.0001)

Grade (continuous)

3.25 (1.58–6.69, 0.0014)

 

PgR+

1.0 (referent)

 

PgR-

3.45 (1.22–9.80, 0.02)

 
  1. ER, oestrogen receptor; PgR, progesterone receptor.